Pitavastatin Market Size, Share & Trends Analysis Report, By Type (1 mg, 2 mg and 5 mg), By Product Type (Tablets, Capsules and Oral Solution), By Application (Hyperlipidemia and Cardiovascular Disease Prevention), By End-user (Hospitals, Clinics, Retail Pharmacies, And Online Pharmacies), By Region, Forecasts, 2024-2031
Pitavastatin Market Size was valued at USD 537.1 Mn in 2023 and is predicted to reach USD 890.2 Mn by 2031 at a 6.7% CAGR during the forecast period for 2024-2031. The increasing awareness of preventive healthcare measures and the significance of managing cardiovascular risk factors are driving the demand for pitavastatin as a preventive medication. Opportunities exist to expand the global reach of the pitavastatin market, tap into emerging ma...
Report ID: 2421 |
Delivery: Immediate |
Published: March 2024 |
No. of Pages: 179
DTC Wellness Testing Market Size, Share & Trends Analysis Report By Type (Genetic Testing, Metabolic Testing, Nutritional Testing, Hormone Testing, Others), By Application (Disease Risk Assessment, Ancestry Testing, Fitness and Nutrition, Personalized Medicine, Others), By Product, By Technology, Region And Segment Forecasts, 2024-2031
Global DTC Wellness Testing Market Size is valued at USD 973.30 Mn in 2023 and is predicted to reach USD 3,518.77 Mn by the year 2031 at a 17.79% CAGR during the forecast period for 2024-2031. The global market for (DTC) genetic testing encompasses regions where genetic testing services and products are directly marketed and sold to consumers, bypassing medical professionals or intermediaries. DTC genetic testing enables individuals to obtain ...
Report ID: 2317 |
Delivery: Immediate |
Published: March 2024 |
No. of Pages: 180
Genome Editing/Genome Engineering Market Size, Share & Trends Analysis Report By Technology (CRISPR, TALEN, ZFN, Antisense, and Other Technologies), By Products, By Application, By End Users, Region And Segment Forecasts, 2023-2031.
The Genome Editing/Genome Engineering Market Size is valued at 5900.0 Million in 2022 and is predicted to reach 28469.3 Million by the year 2031 at a 19.20 % CAGR during the forecast period for 2023-2031. Genome engineering is the technique that involves gene modification by certain process include DNA is insertion, cutting, modification or replacement of genome of a living organism. Due to increasing the research and development spend by comp...
Report ID: 1174 |
Delivery: Immediate |
Published: March 2024 |
No. of Pages: 180
Alpha 1 Lung Disease Market Size, Share & Trends Analysis Report By Disease Type (Alpha-1 Antitrypsin Deficiency, Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Fibrosis, Bronchiectasis, Others), By Treatment Type (Augmentation Therapy, Bronchodilators, Corticosteroids, Oxygen Therapy, Lung Transplantation, Others), By Route of Administration, By Distribution Channel, By End User, By Region, And By Segment Forecasts, 2023-2031.
Alpha 1 Lung Disease Market Size is valued at USD 4.13 Billion in 2022 and is predicted to reach USD 19.93 Billion by the year 2031 at a 19.33% CAGR during the forecast period for 2023-2031. Alpha-1 Antitrypsin Deficiency is a genetic disorder in which the body does not make enough of a protein known as alpha-1 antitrypsin. This protein is very important for keeping the lungs safe from damage caused by inflammation. People who don't get enough...
Report ID: 2274 |
Delivery: Immediate |
Published: March 2024 |
No. of Pages: 180
Nucleic Acid Sample Preparation Market Size, Share & Trends Analysis Report By Product (Consumables (Kits (DNA/RNA Sample Isolation/Extraction/Purification, DNA/RNA Clean-Up and Concentration, DNA and RNA Quantification), Reagents), Instruments), By Technology (Silica-Based, Magnetic Particle Technology), By Source Type, By Application, By End-user, By Region, And By Segment Forecasts, 2024-2031
Nucleic Acid Sample Preparation Market Size is valued at USD 2.89 Billion in 2023 and is predicted to reach USD 4.57 Billion by the year 2031 at a 6.10% CAGR during the forecast period for 2024-2031. Molecular biology relies on nucleic acid sample preparation to extract, purify, and concentrate DNA or RNA from blood, tissue, cell, and environmental samples. High-quality nucleic acids are essential for genetic and molecular analysis like PCR, N...
Report ID: 2386 |
Delivery: Immediate |
Published: March 2024 |
No. of Pages: 179
Swab And Viral Transport Medium Market Size, Share & Trends Analysis Report By Product (Swab Type (Nasal Swabs, Nasopharyngeal Swabs and Throat Swabs), Transport Medium), By Application, By End-User, By Region, And By Segment Forecasts, 2024-2031
The Swab And Viral Transport Medium Market Size is valued at 8.09 Billion in 2023 and is predicted to reach 13.16 Billion by the year 2031 at a 6.47 % CAGR during the forecast period for 2024-2031. Viral transport medium is used to collect, transport, maintain and store the clinical specimens containing viruses, chlamydia, mycoplasma or ureaplasma organisms. A viral skin swab is lightly rubbed against a visible skin lesion or vesicle and ...
Report ID: 1125 |
Delivery: Immediate |
Published: March 2024 |
No. of Pages: 180
Combo IVD Market Size, Share & Trends Analysis Report By Test Type (SARS-CoV-2 Flu A/B Combo Test, COVID-19, Influenza A/B, RSV Combo test, COVID-19 IgM/IgG Combo Test, HIV-1/2 Ag/Ab Combo Test, HIV/Syphilis Ab Combo Test, HIV, HBsAg, HCV & Syphilis Combo, hCG Combo Test, Thrombophilia Detection Combo Test, Other Test Types), By Testing, By End-User, By Channel, By Sample Type, By Region, And By Segment Forecasts, 2024-2031
Combo IVD Market Size is valued at USD 550.12 Mn in 2023 and is predicted to reach USD 920.86 Mn by the year 2031 at a 6.84% CAGR during the forecast period for 2024-2031. Combo in vitro diagnostics (IVDs) refers to medical tools that measure and analyze biological samples in a controlled environment. These tests are useful for detecting and monitoring a wide range of medical illnesses, including infectious disorders and autoimmune diseases. T...
Report ID: 2376 |
Delivery: Immediate |
Published: March 2024 |
No. of Pages: 180
Coagulation Factor Deficiency Market Size, Share & Trends Analysis Report By Deficiency Type (Hemophilia A, Hemophilia B, Von Willebrand Disease, Factor XI Deficiency, Factor XIII Deficiency, and Others), By Product Type, By End Users, By Region, And By Segment Forecasts, 2024-2031
Coagulation Factor Deficiency Market Size is valued at USD 5.50 Bn in 2023 and is predicted to reach USD 9.60 Bn by the year 2031 at a 7.36% CAGR during the forecast period for 2024-2031. Coagulation factor deficiency refers to a medical disorder characterized by an inadequate or malfunctioning of coagulation factors, which are proteins responsible for blood clotting. This can result in hemorrhagic diseases, manifesting as signs suc...
Report ID: 2163 |
Delivery: Immediate |
Published: March 2024 |
No. of Pages: 179
Chapel Disease Therapeutics Market Size, Share & Trends Analysis Report By Type (Eculizumab, Ravulizumab, Veopoz), By Diagnosis (Gastrointestinal Symptoms, Edema, Hypoalbuminemia, Hypogammaglobulinemia, Malnutrition), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), By Region, And By Segment Forecasts, 2024-2031
Chapel Disease Therapeutics Market Size is valued at USD 144.89 Mn in 2023 and is predicted to reach USD 161.10 Mn by the year 2031 at a 1.41% CAGR during the forecast period for 2024-2031. Chapel Syndrome is a rare genetic condition affecting the immune system. CHAPLE stands for "CD55 deficiency, hyperactivation, angiopathic thrombosis, and severe protein-losing enteropathy (PLE)." Chaple is characterized by severe protein-losing enteropathy,...
Report ID: 2360 |
Delivery: Immediate |
Published: March 2024 |
No. of Pages: 180
Omics-Based Clinical Trials Market Size, Share & Trends Analysis Report By Phase Type (Phase I, Phase II, Phase III, and Phase IV), By Study Design Type (Interventional Studies, Observational Studies, and Expanded Access Studies), By Indication Type (Oncology, Cardiology, Respiratory Diseases, Skin Diseases, CNS Diseases, Immunology, Genetic Diseases, and Others), By Region, And By Segment Forecasts, 2024-2031
Omics-Based Clinical Trials Market Size is valued at USD 29.51 billion in 2023 and is predicted to reach USD 54.42 billion by the year 2031 at a 8.13% CAGR during the forecast period for 2023-2031. Omics-based clinical trials represent a significant shift towards more precise and personalized healthcare, offering the promise of better-targeted therapies with higher efficacy and fewer side effects. As the field evolves, continued advancements i...
Report ID: 2355 |
Delivery: Immediate |
Published: March 2024 |
No. of Pages: 180
Pharmaceuticals